Table 1.
n=17 | |
---|---|
Age, median (range) | 57.9 (34-90) |
Sex, n (%) | |
Female | 17 (100) |
Race, n (%) | |
Caucasian | 14 (82) |
Asian | 2 (12) |
Unknown | 1 (6) |
Stage at Diagnosis, n (%) | |
I | 3 (18) |
II | 9 (53) |
III | 4 (24) |
IV | 1 (6) |
Sites of Metastatic Disease, n (%) | |
Visceral | 12 (71) |
No visceral disease | 5 (29) |
Median lines prior therapy# (range) | 2 (0-6) |
Median number of treatment cycles on study (range) | 3 (1-8) |
In metastatic setting. Adjuvant therapy excluded.